2012
DOI: 10.1093/ageing/afs039
|View full text |Cite
|
Sign up to set email alerts
|

Managing patients with COPD exacerbation: does age matter?

Abstract: clinicians should consider increasing age as a specific risk factor in the management of COPD. Acute units and community teams should review carefully their protocols and pathways for how they assess, manage, discharge and follow-up older patients with COPD exacerbation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
18
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(24 citation statements)
references
References 7 publications
5
18
0
1
Order By: Relevance
“… 20 Stone et al showed older people admitted with AECOPD had more severe symptoms and comorbidity prior to exacerbation and higher in-patient/90-day mortality following exacerbation. 21 In our study, every ten years of age increased the risk of re-exacerbation in 90 days after discharge from hospital (OR =1.359). Therefore, age category was selected as a parameter of the re-AE INDEX, which increased the sensitivity and specificity of the predictive power compared with that without age category (data not shown).…”
Section: Discussionsupporting
confidence: 44%
“… 20 Stone et al showed older people admitted with AECOPD had more severe symptoms and comorbidity prior to exacerbation and higher in-patient/90-day mortality following exacerbation. 21 In our study, every ten years of age increased the risk of re-exacerbation in 90 days after discharge from hospital (OR =1.359). Therefore, age category was selected as a parameter of the re-AE INDEX, which increased the sensitivity and specificity of the predictive power compared with that without age category (data not shown).…”
Section: Discussionsupporting
confidence: 44%
“…In other studies, age was an independent predictor of mortality during one-year of follow-up after hospitalization for an eCOPD [ 14 , 15 ]. It must be noted, however, that age is a stronger predictor of long-term mortality following eCOPD hospitalization than it is as a predictor for in-hospital mortality [ 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…In patients with high occurrence of exacerbations (especially if post-BD FEV 1 ≤60% of the predicted value) it is advisable to include a combination of LABA and inhaled corticosteroid (ICS) in the therapy 3,47,59,60,79 . Evidence for the effectiveness of LAMA + ICS is still lacking.…”
Section: Additional Components Of the Standard Treatmentmentioning
confidence: 99%